Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants
- PMID: 37962671
- DOI: 10.1007/s00439-023-02613-6
Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants
Abstract
To investigate the genotype-to-protein-to-phenotype correlations of succinic semialdehyde dehydrogenase deficiency (SSADHD), an inherited metabolic disorder of γ-aminobutyric acid catabolism. Bioinformatics and in silico mutagenesis analyses of ALDH5A1 variants were performed to evaluate their impact on protein stability, active site and co-factor binding domains, splicing, and homotetramer formation. Protein abnormalities were then correlated with a validated disease-specific clinical severity score and neurological, neuropsychological, biochemical, neuroimaging, and neurophysiological metrics. A total of 58 individuals (1:1 male/female ratio) were affected by 32 ALDH5A1 pathogenic variants, eight of which were novel. Compared to individuals with single homotetrameric or multiple homo and heterotetrameric proteins, those predicted not to synthesize any functional enzyme protein had significantly lower expression of ALDH5A1 (p = 0.001), worse overall clinical outcomes (p = 0.008) and specifically more severe cognitive deficits (p = 0.01), epilepsy (p = 0.04) and psychiatric morbidity (p = 0.04). Compared to individuals with predictions of having no protein or a protein impaired in catalytic functions, subjects whose proteins were predicted to be impaired in stability, folding, or oligomerization had a better overall clinical outcome (p = 0.02) and adaptive skills (p = 0.04). The quantity and type of enzyme proteins (no protein, single homotetramers, or multiple homo and heterotetramers), as well as their structural and functional impairments (catalytic or stability, folding, or oligomerization), contribute to phenotype severity in SSADHD. These findings are valuable for assessment of disease prognosis and management, including patient selection for gene replacement therapy. Furthermore, they provide a roadmap to determine genotype-to-protein-to-phenotype relationships in other autosomal recessive disorders.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Update of
-
Phenotypic Correlates of Structural and Functional Protein Impairments Resultant from ALDH5A1 Variants.Res Sq [Preprint]. 2023 Jul 10:rs.3.rs-3111263. doi: 10.21203/rs.3.rs-3111263/v1. Res Sq. 2023. Update in: Hum Genet. 2023 Dec;142(12):1755-1776. doi: 10.1007/s00439-023-02613-6. PMID: 37503297 Free PMC article. Updated. Preprint.
Similar articles
-
Phenotypic Correlates of Structural and Functional Protein Impairments Resultant from ALDH5A1 Variants.Res Sq [Preprint]. 2023 Jul 10:rs.3.rs-3111263. doi: 10.21203/rs.3.rs-3111263/v1. Res Sq. 2023. Update in: Hum Genet. 2023 Dec;142(12):1755-1776. doi: 10.1007/s00439-023-02613-6. PMID: 37503297 Free PMC article. Updated. Preprint.
-
Succinic semialdehyde dehydrogenase deficiency: The combination of a novel ALDH5A1 gene mutation and a missense SNP strongly affects SSADH enzyme activity and stability.Mol Genet Metab. 2018 Jul;124(3):210-215. doi: 10.1016/j.ymgme.2018.05.006. Epub 2018 Jun 2. Mol Genet Metab. 2018. PMID: 29895405
-
SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.Metab Brain Dis. 2017 Oct;32(5):1383-1388. doi: 10.1007/s11011-017-0058-5. Epub 2017 Jun 29. Metab Brain Dis. 2017. PMID: 28664505
-
Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1-/- mice, a model of succinic semialdehyde dehydrogenase deficiency.Mol Genet Metab. 2019 Dec;128(4):397-408. doi: 10.1016/j.ymgme.2019.10.003. Epub 2019 Oct 31. Mol Genet Metab. 2019. PMID: 31699650 Review.
-
Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.Neurochem Int. 2016 Oct;99:72-84. doi: 10.1016/j.neuint.2016.06.009. Epub 2016 Jun 14. Neurochem Int. 2016. PMID: 27311541 Free PMC article. Review.
Cited by
-
A crucial active site network of titratable residues guides catalysis and NAD+ binding in human succinic semialdehyde dehydrogenase.Protein Sci. 2025 Jan;34(1):e70024. doi: 10.1002/pro.70024. Protein Sci. 2025. PMID: 39731543 Free PMC article.
-
Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency.Mol Genet Metab. 2024 May;142(1):108363. doi: 10.1016/j.ymgme.2024.108363. Epub 2024 Mar 4. Mol Genet Metab. 2024. PMID: 38452608 Free PMC article.
-
Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability-An Exception or a Necessity?Genes (Basel). 2024 Jun 15;15(6):789. doi: 10.3390/genes15060789. Genes (Basel). 2024. PMID: 38927725 Free PMC article.
-
Functional Characterization of a Spectrum of Genetic Variants in a Family with Succinic Semialdehyde Dehydrogenase Deficiency.Int J Mol Sci. 2024 May 11;25(10):5237. doi: 10.3390/ijms25105237. Int J Mol Sci. 2024. PMID: 38791277 Free PMC article.
-
Clinical features and ALDH5A1 gene findings in 13 Chinese cases with succinic semialdehyde dehydrogenase deficiency.BMC Med Genomics. 2024 Jun 11;17(1):158. doi: 10.1186/s12920-024-01925-4. BMC Med Genomics. 2024. PMID: 38862963 Free PMC article.
References
-
- Achenbach TM, Rescorla LA (2000) Child behavior checklist for ages 1 1/2-5: ASEBA. University of Vermont, Burlington
-
- Achenbach TM, Rescorla LA (2001) Manual for the ASEBA school-age forms & profiles: an integrated system of multi-informant assessment. University of Vermont, Research Center for Children, Youth, & Families, Burlington, p 1617
-
- Achenbach TM, Rescorla L (2003) ASEBA adult forms & profiles: for ages 18–59: adult self-report and adult behavior checklist. Aseba, Burlington
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases